Skip to main content
Log in

Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation

  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

New quinoline derivatives 6, 7 and 19, pyrimidoquinoline derivatives 8–16 and triazolopyrimidoquinoline derivatives 17 and 18 bearing a bromo-substituent were synthesized starting from 3-(4-Bromophenylamino)-5,5-dimethylcyclohex-2-enone 3. All the newly synthesized compounds were evaluated for their in vitro anticancer activity against human breast cancer cell line (MCF7). Compounds 9, 11, 17 and 18 showed IC50 values (36.4, 39.7, 39.02 and 36.4 μM, respectively) comparable to that of the reference drug doxorubicin (IC50 = 32.02 μM). On the other hand, compound 6, 14 and 19 exhibited better activity than doxorubicin with IC50 values of 8.5, 23.5 and 23.7 μM. Additionally, the most potent compounds 6, 14 and 19 were evaluated for their ability to enhance the cell killing effect of γ-radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abouzid, K. and Shouman, S., Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. Bioorg. Med. Chem., 16, 7543–7551 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Al-Ghamdi, M. A., Abd El-Wahab, H. F., Mohamed, M. H., and El-Agrody, M. A., Synthesis and antitumor activities of 4H-pyrano[3,2-h]quinoline-3-carbonitrile, 7H-pyrimido [4′,5′:6,5]pyrano[3,2-h]quinoline, and 14H-pyrimido[4′,5′: 6,5]pyrano[3,2-h][1,2,4]triazolo[1,5-c]quinoline derivatives. Lett. Drug Des. Discov., 9, 459–470 (2012).

    CAS  Google Scholar 

  • Alqasoumi, S. I., Al-Taweel, A. M., Alafeefy, A. M., Noaman, E., and Ghorab, M. M., Novel quinolines and pyrimido[4, 5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents. Eur. J. Med. Chem., 45, 738–744 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Alqasoumi, S. I., Al-Taweel, A. M., Alafeefy, A. M., Hamed, M. M., Noaman, E., and Ghorab, M. M., Synthesis and biological evaluation of 2-amino-7,7-dimethyl 4-substituted-5-oxo-1-(3,4,5-trimethoxy)-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile derivatives as potential cytotoxic agents. Bioorg. Med. Chem. Lett., 19, 6939–6942 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Amr, A. G., Mohamed, A. M., Mohamed, S. F., Abdel-Hafez, N. A., and Hammam, Ael-F., Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives. Bioorg. Med. Chem., 14, 5481–5488 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Behforouz, M., Cai, W., Mohammadi, F., Stocksdale, M. G., Gu, Z., Ahmadian, M., Baty, D. E., Etling, M. R., Al-Anzi, C. H., Swiftney, T. M., Tanzer, L. R., Merriman, R. L., and Behforouz, N. C., Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones. Bioorg. Med. Chem., 15, 495–510 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Chauhan, P. M., Martins, C. J., and Horwell, D. C., Syntheses of novel heterocycles as anticancer agents. Bioorg. Med. Chem., 13, 3513–3518 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Cheng, Y., An, L. K., Wu, N., Wang, X. D., Bu, X. Z., Huang, Z. S., and Gu, L. Q., Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives. Bioorg. Med. Chem., 16, 4617–4625 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Cocco, M. T., Congiu, C., Lilliu, V., and Onnis, V., Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives. Bioorg. Med. Chem., 14, 366–372 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Dogan, H. N., Duran, A., and Rollas, S., Synthesis and preliminary anticancer activity of new 1H-4,5-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-1,2,4-triazoline-5-thiones. Indian J. Chem., 44, 2301–2307 (2005).

    Article  Google Scholar 

  • El-Sayed, O. A., Al-Turki, T. M., Al-Daffiri, H. M., Al-Bassam, B. A., and Hussein, M. E., Tetrazolo[1,5-a] quinoline derivatives as anti-inflammatory and antimicrobial agents [1]. Boll. Chim. Farm., 143, 227–238 (2004).

    PubMed  CAS  Google Scholar 

  • Eswaran, S., Adhikari, A. V., and Ajay Kumar, R., New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties. Eur. J. Med. Chem., 45, 957–966 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Ferlin, M. G., Gatto, B., Chiarelotto, G., and Palumbo, M., Novel pyrrolo[3,2-f]quinolines: synthesis and antiproliferative activity. Bioorg. Med. Chem., 9, 1843–1848 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Ghorab, M. M., Ragab, F. A., Heiba, H. I., and Ghorab, W. M., Design and synthesis of some novel quinoline derivatives as anticancer and radiosensitizing agents targeting VEGFR tyrosine kinase. J. Heterocycl. Chem., 48, 1269–1279 (2011).

    Article  CAS  Google Scholar 

  • Gopal, M., Shenoy, S., and Doddamani, L. S., Antitumor activity of 4-amino and 8-methyl-4-(3-diethylamino propylamino) pyrimido[4′,5′:4,5]thieno (2,3-b) quinolines. J. Photochem. Photobiol., 72, 7543–7551 (2007).

    Google Scholar 

  • Heiniger, B., Gakhar, G., Prasain, K., Hua, D. H., and Nguyen, T. A., Second-generation substituted quinolines as anticancer drugs for breast cancer. Anticancer Res., 30, 3927–3932 (2010).

    PubMed  CAS  Google Scholar 

  • Joshi, A. A., Narkhede, S. S., and Viswanathan, C. L., Design, synthesis and evaluation of 5-substituted amino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as novel antimalarials. Bioorg. Med. Chem. Lett., 15, 73–76 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Kamen, B. A., Cole, P. D., and Bertino, J. R., Chemotherapeutic agents. In Cancer Medicine, Bast, R. C., Kufe, D. W., Pollock, R. E., Weichselbaum, R. R., Holland Frei, J. F., and BCDecke, E. (Eds). 5, 612–705 (2000).

  • Kashyap, S. J., Sharma, P. K., Garg, V. K., Dudhe, R., and Kumar, N., Review on synthesis and various biological potential of thiazolopyrimidine derivatives. J. Adv. Sci. Res., 2, 18–24 (2011).

    CAS  Google Scholar 

  • Kategaonkar, A. H., Pokalwar, R. U., Sonar, S. S., Gawali, V. U., Shingate, B. B., and Shingare, M. S., Synthesis, in vitro antibacterial and antifungal evaluations of new alpha-hydroxyphosphonate and new alpha-acetoxyphosphonate derivatives of tetrazolo [1,5-a] quinoline. Eur. J. Med. Chem., 45, 1128–1132 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Kemnitzer, W., Kuemmerle, J., Jiang, S., Zhang, H. Z., Sirisoma, N., Kasibhatla, S., Crogan-Grundy, C., Tseng, B., Drewe, J., and Cai, S. X., Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions. Bioorg. Med. Chem. Lett., 18, 6259–6264 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Kim, Y. H., Shin, K. J., Lee, T. G., Kim, E., Lee, M. S., Ryu, S. H., and Suh, P. G., G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound. Biochem. Pharmacol., 69, 1333–1341 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Mahmoudian, M. and Rahimi-Moghaddam, P., The anticancer activity of noscapine: a review. Recent Pat. Anticancer Drug Discov., 4, 92–97 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Mani, S., Macapinlac, M., Jr., Goel, S., Verdier-Pinard, D., Fojo, T., Rothenberg, M., and Colevas, D., The clinical development of new mitotic inhibitors that stabilize the microtubule. Anticancer Drugs, 15, 553–558 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Metwally, K., Khalil, A., Pratsinis, H., and Kletsas, D., Synthesis, in-vitro cytotoxicity, and a preliminary structureactivity relationship investigation of pyrimido[4,5-c]quinoline-1(2H)-ones. Arch. Pharm. (Weinheim), 343, 465–472 (2010).

    Article  CAS  Google Scholar 

  • Milner, E., McCalmont, W., Bhonsle, J., Caridha, D., Carroll, D., Gardner, S., Gerena, L., Gettayacamin, M., Lanteri, C., Luong, T., Melendez, V., Moon, J., Roncal, N., Sousa, J., Tungtaeng, A., Wipf, P., and Dow, G., Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum. Bioorg. Med. Chem. Lett., 20, 1347–1351 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Mulvihill, M. J., Ji, Q. S., Coate, H. R., Cooke, A., Dong, H., Feng, L., Foreman, K., Rosenfeld-Franklin, M., Honda, A., Mak, G., Mulvihill, K. M., Nigro, A. I., O’Connor, M., Pirrit, C., Steinig, A. G., Siu, K., Stolz, K. M., Sun, Y., Tavares, P. A., Yao, Y., and Gibson, N. W., Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors. Bioorg. Med. Chem., 16, 1359–1375 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Nishii, H., Chiba, T., Morikami, K., Fukami, T. A., Sakamoto, H., Ko, K., and Koyano, H., Discovery of 6-benzyloxyquinolines as c-Met selective kinase inhibitors. Bioorg. Med. Chem. Lett., 20, 1405–1409 (2010).

    Article  PubMed  CAS  Google Scholar 

  • Nishimura, Y., Rationale for chemoradiotherapy. Int. J. Clin. Oncol., 9, 414–420 (2004).

    Article  PubMed  Google Scholar 

  • Palaska, E., Sahin, G., Kelicen, P., Durlu, N. T., and Altinok, G., Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco, 57, 101–107 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Palit, P., Paira, P., Hazra, A., Banerjee, S., Gupta, A. D., Dastidar, S. G., and Mondal, N. B., Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation. Eur. J. Med. Chem., 44, 845–853 (2009).

    Article  PubMed  CAS  Google Scholar 

  • Pannala, M., Kher, S., Wilson, N., Gaudette, J., Sircar, I., Zhang, S. H., Bakhirev, A., Yang, G., Yuen, P., Gorcsan, F., Sakurai, N., Barbosa, M., and Cheng, J. F., Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors. Bioorg. Med. Chem. Lett., 17, 5978–5982 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Singhal, N., Sharma, P. K., Dudhe, R., and Kumar, N., Recent advancement of triazole derivatives and their biological significance. J. Chem. Pharm. Res., 3, 126–133 (2011).

    CAS  Google Scholar 

  • Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107–1112 (1990).

    Article  PubMed  CAS  Google Scholar 

  • Zhao, Y. L., Chen, Y. L., Chang, F. S., and Tzeng, C. C., Synthesis and cytotoxic evaluation of certain 4-anilino-2-phenylquinoline derivatives. Eur. J. Med. Chem., 40, 792–797 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Zhou, J., Gupta, K., Aggarwal, S., Aneja, R., Chandra, R., Panda, D., and Joshi, H. C., Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation. Mol. Pharmacol., 63, 799–807 (2003).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mostafa M. Ghorab.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghorab, M.M., Ragab, F.A., Heiba, H.I. et al. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation. Arch. Pharm. Res. 35, 1335–1346 (2012). https://doi.org/10.1007/s12272-012-0803-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-012-0803-6

Key words

Navigation